Pfizer to invest $650 million in new Manufacturing Technology Center at Groton campus
+1 new source since this summary was written
Pfizer announced a $650 million capital program to build a 220,000‑square‑foot Manufacturing Technology Center at its Groton, Connecticut R&D campus. Construction is slated to start in the second quarter of 2027, with the facility expected to become operational in mid‑2031. The center will produce clinical‑grade active pharmaceutical ingredients and drug products for Pfizer‑sponsored trials and will bring together employees currently spread across the campus into a single, modern building.
Why it matters
The company says the investment will strengthen its ability to support global clinical trials and modernize its manufacturing footprint, which could enhance future product pipelines (). The sizable capex may affect Pfizer’s cash flow and balance sheet over the next five years, a factor investors will monitor.
Key facts
- 1Pfizer will spend $650 million on the project over the next five years. finance.yahoo.com
- 2The new facility will be about 220,000 square feet. finance.yahoo.com
- 3Construction is planned to begin in the second quarter of 2027. finance.yahoo.com
- 4Operational startup is targeted for mid‑2031. finance.yahoo.com
- 5Pfizer employs roughly 4,000 people at the Groton campus. finance.yahoo.com
- 6The campus is assessed at about $365 million for local taxes. finance.yahoo.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.